NEW HIGHLIGHT
Evenity

Evenity

romosozumab

Manufacturer:

Amgen

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Romosozumab
Indications/Uses
Severe osteoporosis in postmenopausal women at high risk of fracture.
Dosage/Direction for Use
210 mg SC inj once mthly for 12 doses.
Contraindications
Hypersensitivity. Uncorrected hypocalcaemia.
Special Precautions
Discontinue use if anaphylactic or other clinically significant allergic reaction occurs. Not to be initiated in patients who have had MI or stroke w/in preceding yr. Not to be inj into tender, bruised, red or hardened skin areas. Osteonecrosis of the jaw; atypical femoral fractures. Immunogenicity. Correct hypocalcaemia, assess for CV risks & perform dental exam w/ preventive dentistry prior to treatment. Ensure adequate Ca & vit D supplementation. Severe renal impairment or patients receiving dialysis. Not to be used in women of childbearing potential. Pregnancy & lactation. Paed.
Adverse Reactions
Viral upper resp tract infection; arthralgia. Hypersensitivity, rash, dermatitis; headache; cough; neck pain, muscle spasms; peripheral oedema, inj site reactions eg, pain, erythema.
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX06 - romosozumab ; Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Presentation/Packing
Form
Evenity soln for inj 105 mg/1.17 mL
Packing/Price
2 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in